Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients.
Autor*in: |
Abdel-Rahman, O. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2017 |
---|
Schlagwörter: |
---|
Umfang: |
13 |
---|
Übergeordnetes Werk: |
Enthalten in: Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory - Meyer, Theresa ELSEVIER, 2022, a journal of the Royal College of Radiologists, [S.l.] |
---|---|
Übergeordnetes Werk: |
volume:29 ; year:2017 ; number:4 ; pages:218-230 ; extent:13 |
Links: |
---|
DOI / URN: |
10.1016/j.clon.2016.11.007 |
---|
Katalog-ID: |
ELV03601513X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV03601513X | ||
003 | DE-627 | ||
005 | 20230624024843.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.clon.2016.11.007 |2 doi | |
028 | 5 | 2 | |a GBVA2017015000021.pica |
035 | |a (DE-627)ELV03601513X | ||
035 | |a (ELSEVIER)S0936-6555(16)30407-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-101 |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 550 |q VZ |
084 | |a 38.73 |2 bkl | ||
084 | |a 74.41 |2 bkl | ||
100 | 1 | |a Abdel-Rahman, O. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis |
264 | 1 | |c 2017 | |
300 | |a 13 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients. | ||
650 | 7 | |a pembrolizumab |2 Elsevier | |
650 | 7 | |a nivolumab |2 Elsevier | |
650 | 7 | |a tremelimumab |2 Elsevier | |
650 | 7 | |a treatment-related death |2 Elsevier | |
650 | 7 | |a ipilimumab |2 Elsevier | |
650 | 7 | |a Atezolizumab |2 Elsevier | |
700 | 1 | |a Helbling, D. |4 oth | |
700 | 1 | |a Schmidt, J. |4 oth | |
700 | 1 | |a Petrausch, U. |4 oth | |
700 | 1 | |a Giryes, A. |4 oth | |
700 | 1 | |a Mehrabi, A. |4 oth | |
700 | 1 | |a Schöb, O. |4 oth | |
700 | 1 | |a Mannhart, M. |4 oth | |
700 | 1 | |a Oweira, H. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Saunders |a Meyer, Theresa ELSEVIER |t Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory |d 2022 |d a journal of the Royal College of Radiologists |g [S.l.] |w (DE-627)ELV009071989 |
773 | 1 | 8 | |g volume:29 |g year:2017 |g number:4 |g pages:218-230 |g extent:13 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.clon.2016.11.007 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OPC-GGO | ||
912 | |a SSG-OPC-GEO | ||
936 | b | k | |a 38.73 |j Geodäsie |q VZ |
936 | b | k | |a 74.41 |j Luftaufnahmen |j Photogrammetrie |q VZ |
951 | |a AR | ||
952 | |d 29 |j 2017 |e 4 |h 218-230 |g 13 | ||
953 | |2 045F |a 610 |
author_variant |
o a r oar |
---|---|
matchkey_str |
abdelrahmanohelblingdschmidtjpetrauschug:2017----:ramnrltdeticneptettetdihmuehcpitniiosss |
hierarchy_sort_str |
2017 |
bklnumber |
38.73 74.41 |
publishDate |
2017 |
allfields |
10.1016/j.clon.2016.11.007 doi GBVA2017015000021.pica (DE-627)ELV03601513X (ELSEVIER)S0936-6555(16)30407-1 DE-627 ger DE-627 rakwb eng 610 610 DE-101 610 DE-600 550 VZ 38.73 bkl 74.41 bkl Abdel-Rahman, O. verfasserin aut Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis 2017 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients. pembrolizumab Elsevier nivolumab Elsevier tremelimumab Elsevier treatment-related death Elsevier ipilimumab Elsevier Atezolizumab Elsevier Helbling, D. oth Schmidt, J. oth Petrausch, U. oth Giryes, A. oth Mehrabi, A. oth Schöb, O. oth Mannhart, M. oth Oweira, H. oth Enthalten in Saunders Meyer, Theresa ELSEVIER Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory 2022 a journal of the Royal College of Radiologists [S.l.] (DE-627)ELV009071989 volume:29 year:2017 number:4 pages:218-230 extent:13 https://doi.org/10.1016/j.clon.2016.11.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO 38.73 Geodäsie VZ 74.41 Luftaufnahmen Photogrammetrie VZ AR 29 2017 4 218-230 13 045F 610 |
spelling |
10.1016/j.clon.2016.11.007 doi GBVA2017015000021.pica (DE-627)ELV03601513X (ELSEVIER)S0936-6555(16)30407-1 DE-627 ger DE-627 rakwb eng 610 610 DE-101 610 DE-600 550 VZ 38.73 bkl 74.41 bkl Abdel-Rahman, O. verfasserin aut Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis 2017 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients. pembrolizumab Elsevier nivolumab Elsevier tremelimumab Elsevier treatment-related death Elsevier ipilimumab Elsevier Atezolizumab Elsevier Helbling, D. oth Schmidt, J. oth Petrausch, U. oth Giryes, A. oth Mehrabi, A. oth Schöb, O. oth Mannhart, M. oth Oweira, H. oth Enthalten in Saunders Meyer, Theresa ELSEVIER Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory 2022 a journal of the Royal College of Radiologists [S.l.] (DE-627)ELV009071989 volume:29 year:2017 number:4 pages:218-230 extent:13 https://doi.org/10.1016/j.clon.2016.11.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO 38.73 Geodäsie VZ 74.41 Luftaufnahmen Photogrammetrie VZ AR 29 2017 4 218-230 13 045F 610 |
allfields_unstemmed |
10.1016/j.clon.2016.11.007 doi GBVA2017015000021.pica (DE-627)ELV03601513X (ELSEVIER)S0936-6555(16)30407-1 DE-627 ger DE-627 rakwb eng 610 610 DE-101 610 DE-600 550 VZ 38.73 bkl 74.41 bkl Abdel-Rahman, O. verfasserin aut Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis 2017 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients. pembrolizumab Elsevier nivolumab Elsevier tremelimumab Elsevier treatment-related death Elsevier ipilimumab Elsevier Atezolizumab Elsevier Helbling, D. oth Schmidt, J. oth Petrausch, U. oth Giryes, A. oth Mehrabi, A. oth Schöb, O. oth Mannhart, M. oth Oweira, H. oth Enthalten in Saunders Meyer, Theresa ELSEVIER Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory 2022 a journal of the Royal College of Radiologists [S.l.] (DE-627)ELV009071989 volume:29 year:2017 number:4 pages:218-230 extent:13 https://doi.org/10.1016/j.clon.2016.11.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO 38.73 Geodäsie VZ 74.41 Luftaufnahmen Photogrammetrie VZ AR 29 2017 4 218-230 13 045F 610 |
allfieldsGer |
10.1016/j.clon.2016.11.007 doi GBVA2017015000021.pica (DE-627)ELV03601513X (ELSEVIER)S0936-6555(16)30407-1 DE-627 ger DE-627 rakwb eng 610 610 DE-101 610 DE-600 550 VZ 38.73 bkl 74.41 bkl Abdel-Rahman, O. verfasserin aut Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis 2017 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients. pembrolizumab Elsevier nivolumab Elsevier tremelimumab Elsevier treatment-related death Elsevier ipilimumab Elsevier Atezolizumab Elsevier Helbling, D. oth Schmidt, J. oth Petrausch, U. oth Giryes, A. oth Mehrabi, A. oth Schöb, O. oth Mannhart, M. oth Oweira, H. oth Enthalten in Saunders Meyer, Theresa ELSEVIER Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory 2022 a journal of the Royal College of Radiologists [S.l.] (DE-627)ELV009071989 volume:29 year:2017 number:4 pages:218-230 extent:13 https://doi.org/10.1016/j.clon.2016.11.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO 38.73 Geodäsie VZ 74.41 Luftaufnahmen Photogrammetrie VZ AR 29 2017 4 218-230 13 045F 610 |
allfieldsSound |
10.1016/j.clon.2016.11.007 doi GBVA2017015000021.pica (DE-627)ELV03601513X (ELSEVIER)S0936-6555(16)30407-1 DE-627 ger DE-627 rakwb eng 610 610 DE-101 610 DE-600 550 VZ 38.73 bkl 74.41 bkl Abdel-Rahman, O. verfasserin aut Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis 2017 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients. pembrolizumab Elsevier nivolumab Elsevier tremelimumab Elsevier treatment-related death Elsevier ipilimumab Elsevier Atezolizumab Elsevier Helbling, D. oth Schmidt, J. oth Petrausch, U. oth Giryes, A. oth Mehrabi, A. oth Schöb, O. oth Mannhart, M. oth Oweira, H. oth Enthalten in Saunders Meyer, Theresa ELSEVIER Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory 2022 a journal of the Royal College of Radiologists [S.l.] (DE-627)ELV009071989 volume:29 year:2017 number:4 pages:218-230 extent:13 https://doi.org/10.1016/j.clon.2016.11.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO 38.73 Geodäsie VZ 74.41 Luftaufnahmen Photogrammetrie VZ AR 29 2017 4 218-230 13 045F 610 |
language |
English |
source |
Enthalten in Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory [S.l.] volume:29 year:2017 number:4 pages:218-230 extent:13 |
sourceStr |
Enthalten in Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory [S.l.] volume:29 year:2017 number:4 pages:218-230 extent:13 |
format_phy_str_mv |
Article |
bklname |
Geodäsie Luftaufnahmen Photogrammetrie |
institution |
findex.gbv.de |
topic_facet |
pembrolizumab nivolumab tremelimumab treatment-related death ipilimumab Atezolizumab |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory |
authorswithroles_txt_mv |
Abdel-Rahman, O. @@aut@@ Helbling, D. @@oth@@ Schmidt, J. @@oth@@ Petrausch, U. @@oth@@ Giryes, A. @@oth@@ Mehrabi, A. @@oth@@ Schöb, O. @@oth@@ Mannhart, M. @@oth@@ Oweira, H. @@oth@@ |
publishDateDaySort_date |
2017-01-01T00:00:00Z |
hierarchy_top_id |
ELV009071989 |
dewey-sort |
3610 |
id |
ELV03601513X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV03601513X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624024843.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clon.2016.11.007</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017015000021.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV03601513X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0936-6555(16)30407-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-101</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">550</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.73</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">74.41</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Abdel-Rahman, O.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">pembrolizumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">nivolumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">tremelimumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">treatment-related death</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ipilimumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Atezolizumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Helbling, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schmidt, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petrausch, U.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Giryes, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mehrabi, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schöb, O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mannhart, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Oweira, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Saunders</subfield><subfield code="a">Meyer, Theresa ELSEVIER</subfield><subfield code="t">Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory</subfield><subfield code="d">2022</subfield><subfield code="d">a journal of the Royal College of Radiologists</subfield><subfield code="g">[S.l.]</subfield><subfield code="w">(DE-627)ELV009071989</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:29</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:218-230</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clon.2016.11.007</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GEO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.73</subfield><subfield code="j">Geodäsie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">74.41</subfield><subfield code="j">Luftaufnahmen</subfield><subfield code="j">Photogrammetrie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">29</subfield><subfield code="j">2017</subfield><subfield code="e">4</subfield><subfield code="h">218-230</subfield><subfield code="g">13</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Abdel-Rahman, O. |
spellingShingle |
Abdel-Rahman, O. ddc 610 ddc 550 bkl 38.73 bkl 74.41 Elsevier pembrolizumab Elsevier nivolumab Elsevier tremelimumab Elsevier treatment-related death Elsevier ipilimumab Elsevier Atezolizumab Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis |
authorStr |
Abdel-Rahman, O. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV009071989 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 550 - Earth sciences |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-101 610 DE-600 550 VZ 38.73 bkl 74.41 bkl Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis pembrolizumab Elsevier nivolumab Elsevier tremelimumab Elsevier treatment-related death Elsevier ipilimumab Elsevier Atezolizumab Elsevier |
topic |
ddc 610 ddc 550 bkl 38.73 bkl 74.41 Elsevier pembrolizumab Elsevier nivolumab Elsevier tremelimumab Elsevier treatment-related death Elsevier ipilimumab Elsevier Atezolizumab |
topic_unstemmed |
ddc 610 ddc 550 bkl 38.73 bkl 74.41 Elsevier pembrolizumab Elsevier nivolumab Elsevier tremelimumab Elsevier treatment-related death Elsevier ipilimumab Elsevier Atezolizumab |
topic_browse |
ddc 610 ddc 550 bkl 38.73 bkl 74.41 Elsevier pembrolizumab Elsevier nivolumab Elsevier tremelimumab Elsevier treatment-related death Elsevier ipilimumab Elsevier Atezolizumab |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
d h dh j s js u p up a g ag a m am o s os m m mm h o ho |
hierarchy_parent_title |
Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory |
hierarchy_parent_id |
ELV009071989 |
dewey-tens |
610 - Medicine & health 550 - Earth sciences & geology |
hierarchy_top_title |
Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV009071989 |
title |
Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis |
ctrlnum |
(DE-627)ELV03601513X (ELSEVIER)S0936-6555(16)30407-1 |
title_full |
Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis |
author_sort |
Abdel-Rahman, O. |
journal |
Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory |
journalStr |
Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 500 - Science |
recordtype |
marc |
publishDateSort |
2017 |
contenttype_str_mv |
zzz |
container_start_page |
218 |
author_browse |
Abdel-Rahman, O. |
container_volume |
29 |
physical |
13 |
class |
610 610 DE-101 610 DE-600 550 VZ 38.73 bkl 74.41 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Abdel-Rahman, O. |
doi_str_mv |
10.1016/j.clon.2016.11.007 |
dewey-full |
610 550 |
title_sort |
treatment-related death in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis |
title_auth |
Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis |
abstract |
We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients. |
abstractGer |
We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients. |
abstract_unstemmed |
We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO SSG-OPC-GEO |
container_issue |
4 |
title_short |
Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis |
url |
https://doi.org/10.1016/j.clon.2016.11.007 |
remote_bool |
true |
author2 |
Helbling, D. Schmidt, J. Petrausch, U. Giryes, A. Mehrabi, A. Schöb, O. Mannhart, M. Oweira, H. |
author2Str |
Helbling, D. Schmidt, J. Petrausch, U. Giryes, A. Mehrabi, A. Schöb, O. Mannhart, M. Oweira, H. |
ppnlink |
ELV009071989 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.clon.2016.11.007 |
up_date |
2024-07-06T19:04:22.597Z |
_version_ |
1803857598975311872 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV03601513X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624024843.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clon.2016.11.007</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017015000021.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV03601513X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0936-6555(16)30407-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-101</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">550</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.73</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">74.41</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Abdel-Rahman, O.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">pembrolizumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">nivolumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">tremelimumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">treatment-related death</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ipilimumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Atezolizumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Helbling, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schmidt, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petrausch, U.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Giryes, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mehrabi, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schöb, O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mannhart, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Oweira, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Saunders</subfield><subfield code="a">Meyer, Theresa ELSEVIER</subfield><subfield code="t">Geometric BIM verification of indoor construction sites by photogrammetric point clouds and evidence theory</subfield><subfield code="d">2022</subfield><subfield code="d">a journal of the Royal College of Radiologists</subfield><subfield code="g">[S.l.]</subfield><subfield code="w">(DE-627)ELV009071989</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:29</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:218-230</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clon.2016.11.007</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GEO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.73</subfield><subfield code="j">Geodäsie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">74.41</subfield><subfield code="j">Luftaufnahmen</subfield><subfield code="j">Photogrammetrie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">29</subfield><subfield code="j">2017</subfield><subfield code="e">4</subfield><subfield code="h">218-230</subfield><subfield code="g">13</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.401457 |